Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Jay Venkatesan Insider Profile
4 Followers
Jay Venkatesan, EVP and General Manager at Cascadian Therapeutics, holds 180.53K shares in Elicio Therapeutics (Ticker: ELTX), holds 2.88M shares in Alpine Immune Sciences (Ticker: ALPN), holds 672.29K shares in Exicure (Ticker: XCUR). Most recently, Jay Venkatesan Bought ― shares of Elicio Therapeutics on Nov 29, 2024 for an estimated value of 500.00.
Jay Venkatesan Cascadian Therapeutics (CASC)EVP and General Manager
Cascadian Therapeutics (CASC)
EVP and General Manager
Ranked #93,731 out of 99,797 Corporate Insiders
Profitable Transactions
1 out of 10 Profitable Transactions
Average Return
-35.60%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Jay Venkatesan holds in companies
Most Profitable Insider Trade
Stock:
Alpine Immune Sciences
(ALPN)
(ALPN)
Rating:Informative Sell
Date:Sep 21, 2021 - Sep 21, 2022
Return:+28.40%
The most profitable trade made by Jay Venkatesan
Jay Venkatesan's Trading History
Cascadian Therapeutics
Sep 25, 2014
―
Uninformative Buy
500.00K
$43.49M
Alpine Immune Sciences
Sep 21, 2021
―
Informative Sell
3.76M
$186.88M
Exicure
Jul 08, 2020
Director
Uninformative Buy
19.37K
$12.55M
Elicio Therapeutics
Nov 29, 2024
Director
Informative Buy
500.00
$881.01K
Iovance Biotherapeutics
―
Director
―
$0.00
List of latest transactions for each holding click on a transaction to see Jay Venkatesan's performance on stock
You May Also Like
Jay Venkatesan insider profile FAQ
What is the percentage of profitable transactions made by Jay Venkatesan?
The percentage of profitable transactions made by Jay Venkatesan is 10%.
What is the average return per transaction made by Jay Venkatesan?
The average return per transaction made by Jay Venkatesan is -35.60%.
What stocks does Jay Venkatesan hold?
Jay Venkatesan holds: CASC, ALPN, XCUR, ELTX, IOVA stocks.
What was Jay Venkatesan’s latest transaction?
Jay Venkatesan latest transaction was an Informative Buy of $500.00.
What was Jay Venkatesan's most profitable transaction?
Jay Venkatesan’s most profitable transaction was an Informative Sell of ALPN stock on September 21, 2021. The return on the trade was 28.40%.
What is Jay Venkatesan's role in Cascadian Therapeutics?
Jay Venkatesan's role in Cascadian Therapeutics is EVP and General Manager.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.